ERAS Erasca, Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 11, 2026
$14.74
· of 52w range
· above low
· to high
$2.1152w low
$24.2852w high
Market Cap (MRQ)
$4.61B
P/E
-33.5
EPS
$-0.44
your badges
52W Range
$2–$24
Analyst Rating
BUY
Price Target
$24
P/E
-33.5
ROE
-35.7%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
ERAS Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$14.74
Market Cap (MRQ)
$4.61B
P/E
-33.5
EPS
$-0.44
ROE
-35.7%
52W Range
$2–$24
ERAS Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
EPS$-0.442021-12-31 → 2025-12-31
Free Cash Flow$-96M2021-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | ERAS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -33.55Y avg ≈-5.0 | ≈-5.0 | · | · | |
| P/B (MRQ) | 12.75Y avg ≈2.3 | ≈2.3 | 5.2 | Overvalued | |
| Price / FCF (TTM) | -47.05Y avg ≈-9.3 | ≈-9.3 | · | · | |
| Price / Cash Flow (TTM) | -47.05Y avg ≈-10.1 | ≈-10.1 | · | · | |
| Price / Tangible Book | 12.95Y avg ≈2.3 | ≈2.3 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | ERAS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -27.7%5Y avg ≈-35.6% | ≈-35.6% | -25.8% | In line | |
| ROE | -35.7%5Y avg ≈-39.9% | ≈-39.9% | -38.2% | In line | |
| ROIC | -43.3% | · | -9.7% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | ERAS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 8.35Y avg ≈11.4 | ≈11.4 | 8.9 | Low liquidity | |
| Quick Ratio | 9.75Y avg ≈11.2 | ≈11.2 | 8.0 | In line |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-34.1%
Next Report
Nov 10, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 10, 2026 | $-0.14 | $-0.10 | -34.7% |
| March 31, 2026 | May 11, 2026 | $-0.60 | $-0.21 | -181.6% |
| Dec. 31, 2025 | $-0.10 | $-0.11 | 8.3% | |
| Sept. 30, 2025 | $-0.11 | $-0.11 | -4.4% | |
| June 30, 2025 | $-0.12 | $-0.11 | -7.0% | |
| March 31, 2025 | $-0.11 | $-0.13 | 14.4% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| SG&A Expense | $39M | $42M | $38M | $33M | $23M | $8M | |
| Operating Expenses | $141M | $180M | $142M | $247M | $125M | $109M | |
| Operating Income | $-141M | $-180M | $-142M | $-247M | $-125M | $-109M | |
| Other Non-op | $16M | $18M | $16M | $5M | $314.0K | $-102.0K | |
| Pretax Income | $-125M | $-162M | · | · | · | · | |
| Income Tax | $0 | $0 | · | · | · | · | |
| Net Income | $-125M | $-162M | $-125M | $-243M | $-123M | $-102M | |
| EPS (Basic) | $-0.44 | $-0.69 | $-0.83 | $-1.99 | $-1.85 | · | |
| EPS (Diluted) | $-0.44 | $-0.69 | $-0.83 | $-1.99 | $-1.85 | · | |
| Shares (Basic) | 283,533,696 | 233,817,916 | 150,184,994 | 122,024,848 | 66,290,592 | · | |
| Shares (Diluted) | 283,533,696 | 233,817,916 | 150,184,994 | 122,024,848 | 66,290,592 | · | |
| EBITDA | $-138M | $-176M | $-138M | $-245M | $-124M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $74M | $68M | $93M | $284M | $360M | $65M | |
| Short-term Investments | $202M | $231M | $219M | $151M | $54M | $53M | |
| Prepaid Expense | $10M | $10M | $8M | $9M | $6M | $1M | |
| Current Assets | $286M | $309M | $321M | $444M | $420M | $120M | |
| PP&E (Net) | $13M | $16M | $22M | $25M | $16M | $2M | |
| PP&E (Gross) | $26M | $26M | $30M | $28M | $18M | $3M | |
| Accum. Depreciation | $13M | $10M | $7M | $4M | $2M | $902.0K | |
| Other Non-current Assets | $1M | $3M | $4M | $5M | $3M | $451.0K | |
| Total Assets | $396M | $503M | $395M | $515M | $501M | $125M | |
| Accounts Payable | $981.0K | $468.0K | $2M | $23M | $5M | $878.0K | |
| Current Liabilities | $29M | $31M | $26M | $49M | $26M | $14M | |
| Capital Leases | $42M | $47M | $52M | $54M | $19M | $2M | |
| Other Non-current Liabilities | $399.0K | $362.0K | $566.0K | $573.0K | $158.0K | · | |
| Total Liabilities | $71M | $79M | $79M | $103M | $45M | $17M | |
| Common Stock | $28.0K | $28.0K | $15.0K | $15.0K | $12.0K | $3.0K | |
| Retained Earnings | $-892M | $-768M | $-606M | $-481M | $-238M | $-115M | |
| AOCI | $628.0K | $405.0K | $77.0K | $-1M | $-162.0K | $2.0K | |
| Stockholders' Equity | $325M | $423M | $317M | $412M | $457M | $-114M | |
| Liabilities + Equity | $396M | $503M | $395M | $515M | $501M | $125M | |
| Shares Outstanding | 284,159,076 | 283,218,344 | 151,090,227 | 149,333,258 | 119,102,505 | 21,923,173 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $3M | $4M | $4M | $3M | $829.0K | $540.0K | |
| Stock-based Comp | $25M | $27M | $26M | $20M | $8M | $797.0K | |
| Other Non-cash | $1M | $21M | $-6M | $117M | $34M | · | |
| Operating Cash Flow | $-95M | $-109M | $-101M | $-103M | $-80M | $-33M | |
| CapEx | $128.0K | $60.0K | $2M | $15M | $11M | $947.0K | |
| Investing Cash Flow | $100M | $-157M | $-91M | $-71M | $-65M | $-71M | |
| Stock Issued | · | · | · | $95M | · | · | |
| Net Stock Activity | · | · | · | $95M | · | · | |
| Financing Cash Flow | $1M | $241M | $1M | $98M | $439M | $140M | |
| Net Change in Cash | $6M | $-25M | $-191M | $-76M | $295M | $36M | |
| Free Cash Flow | $-96M | $-109M | $-103M | $-118M | $-91M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -27.7% | -36.0% | -27.5% | -47.8% | -39.2% | · | |
| ROE | -35.7% | -37.0% | -38.1% | -62.5% | -26.1% | · | |
| ROIC | -43.3% | · | · | · | · | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 10.0 | 9.8 | 12.3 | 9.1 | 15.9 | · | |
| Quick Ratio | 9.7 | 9.5 | 11.9 | 8.9 | 15.7 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.14 | $1.50 | $2.10 | $2.76 | $3.83 | · | |
| Cash Flow / Share | $-0.34 | $-0.47 | $-0.67 | $-0.85 | · | · | |
| Cash / Share | $0.26 | $0.24 | $0.62 | $1.90 | $3.03 | · | |
| Dividend / Share | $0.00 | $0.00 | $0.00 | $0.00 | · | · | |
| EPS (TTM) | $-0.44 | $-0.69 | $-0.83 | $-1.99 | $-1.85 | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-125M | $-162M | $-125M | $-243M | $-123M | · | |
| Market Cap | $1.06B | $711M | $322M | $644M | $1.86B | · | |
| P/E | -8.5 | -3.6 | -2.6 | -2.2 | -8.4 | · | |
| P/B | 3.3 | 1.7 | 1.0 | 1.6 | 4.1 | · | |
| P / Tangible Book | 3.3 | 1.7 | 1.0 | 1.6 | 4.1 | · | |
| P / Cash Flow | -11.1 | -6.5 | -3.2 | -6.2 | -23.3 | · | |
| P / FCF | -11.1 | -6.5 | -3.1 | -5.5 | -20.4 | · | |
| Earnings Yield | -11.8% | -27.5% | -39.0% | -46.2% | -11.9% | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SG&A Expense | $12M | $11M | $9M | $10M | $9M | $10M | $10M | $10M | $12M | $10M | $9M | $9M | $10M | $9M | $9M | $9M | |
| Operating Expenses | $48M | $188M | $33M | $35M | $38M | $36M | $36M | $37M | $68M | $39M | $34M | $35M | $36M | $37M | $138M | $37M | |
| Operating Income | $-48M | $-188M | $-33M | $-35M | $-38M | $-36M | $-36M | $-37M | $-68M | $-39M | $-34M | $-35M | $-36M | $-37M | $-138M | $-37M | |
| Other Non-op | $4M | $22.0K | $7M | $-37.0K | $4M | $-76.0K | $9M | $173.0K | $5M | $4M | $9M | $-49.0K | $4M | $4M | $3M | $1M | |
| Net Income | $-44M | $-183M | $-29M | $-31M | $-34M | $-31M | $-32M | $-31M | $-63M | $-35M | $-30M | $-30M | $-32M | $-33M | $-135M | $-35M | |
| EPS (Basic) | $-0.14 | $-0.60 | $-0.10 | $-0.11 | $-0.12 | $-0.11 | $-0.06 | $-0.11 | $-0.29 | $-0.23 | $-0.20 | $-0.20 | $-0.21 | $-0.22 | $-1.09 | $-0.29 | |
| EPS (Diluted) | $-0.14 | $-0.60 | $-0.10 | $-0.11 | $-0.12 | $-0.11 | $-0.06 | $-0.11 | $-0.29 | $-0.23 | $-0.20 | $-0.20 | $-0.21 | $-0.22 | $-1.09 | $-0.29 | |
| Shares (Basic) | 311,336,806 | 304,317,460 | · | 283,681,570 | 283,355,730 | 283,260,289 | · | 282,384,964 | 217,806,567 | 151,161,741 | · | 150,450,201 | 150,037,029 | 149,504,216 | · | 120,798,322 | |
| Shares (Diluted) | 311,336,806 | 304,317,460 | · | 283,681,570 | 283,355,730 | 283,260,289 | · | 282,384,964 | 217,806,567 | 151,161,741 | · | 150,450,201 | 150,037,029 | 149,504,216 | · | 120,798,322 | |
| EBITDA | $-47M | $-187M | · | $-34M | $-37M | $-35M | · | $-36M | $-67M | $-38M | · | $-34M | $-35M | $-36M | · | $-36M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $43M | $47M | $74M | $70M | $66M | $70M | $68M | $69M | $173M | $77M | $93M | $113M | $139M | $273M | $284M | $219M | |
| Short-term Investments | $226M | $197M | $202M | $218M | $235M | $234M | $231M | $250M | $236M | $221M | $219M | $184M | $178M | $117M | $151M | $137M | |
| Prepaid Expense | $10M | $10M | $10M | $12M | $10M | $10M | $10M | $11M | $10M | $9M | $8M | $9M | $7M | $8M | $9M | $10M | |
| Current Assets | $278M | $254M | $286M | $300M | $311M | $315M | $309M | $330M | $418M | $307M | $321M | $306M | $324M | $398M | $444M | $366M | |
| PP&E (Net) | $12M | $13M | $13M | $14M | $15M | $16M | $16M | $17M | $18M | $21M | $22M | $23M | $24M | $25M | $25M | $25M | |
| PP&E (Gross) | $26M | $26M | $26M | $26M | $26M | $26M | $26M | $26M | $26M | $30M | $30M | $30M | $29M | $29M | $28M | $27M | |
| Accum. Depreciation | $14M | $13M | $13M | $12M | $11M | $11M | $10M | $9M | $8M | $8M | $7M | $6M | $5M | $4M | $4M | $3M | |
| Other Non-current Assets | $1M | $1M | $1M | $2M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | |
| Total Assets | $435M | $461M | $396M | $420M | $445M | $471M | $503M | $529M | $526M | $370M | $395M | $419M | $441M | $468M | $515M | $446M | |
| Accounts Payable | $2M | $2M | $981.0K | $3M | $2M | $2M | $468.0K | $2M | $2M | $3M | $2M | $4M | $3M | $3M | $23M | $4M | |
| Current Liabilities | $34M | $27M | $29M | $29M | $28M | $25M | $31M | $30M | $25M | $30M | $26M | $27M | $23M | $26M | $49M | $28M | |
| Capital Leases | $39M | $41M | $42M | $43M | $45M | $46M | $47M | $48M | $50M | $51M | $52M | $53M | $54M | $55M | $54M | $53M | |
| Other Non-current Liabilities | $341.0K | $340.0K | $399.0K | $395.0K | $263.0K | $251.0K | $362.0K | $340.0K | $82.0K | $559.0K | $566.0K | $761.0K | $697.0K | $630.0K | $573.0K | · | |
| Total Liabilities | $73M | $68M | $71M | $73M | $73M | $72M | $79M | $79M | $75M | $82M | $79M | $80M | $78M | $81M | $103M | $81M | |
| Common Stock | $31.0K | $31.0K | $28.0K | $28.0K | $28.0K | $28.0K | $28.0K | $28.0K | $27.0K | $15.0K | $15.0K | $15.0K | $15.0K | $15.0K | $15.0K | $12.0K | |
| Retained Earnings | $-1.12B | $-1.08B | $-892M | $-863M | $-833M | $-799M | $-768M | $-735M | $-704M | $-641M | $-606M | $-576M | $-546M | $-514M | $-481M | $-346M | |
| AOCI | $-1M | $-699.0K | $628.0K | $649.0K | $415.0K | $628.0K | $405.0K | $2M | $-196.0K | $-210.0K | $77.0K | $-575.0K | $-793.0K | $-514.0K | $-1M | $-1M | |
| Stockholders' Equity | $362M | $394M | $325M | $348M | $372M | $400M | $423M | $450M | $451M | $288M | $317M | $339M | $363M | $386M | $412M | $365M | |
| Liabilities + Equity | $435M | $461M | $396M | $420M | $445M | $471M | $503M | $529M | $526M | $370M | $395M | $419M | $441M | $468M | $515M | $446M | |
| Shares Outstanding | 312,556,206 | 310,806,888 | 284,159,076 | 283,711,805 | 283,650,139 | 283,265,716 | 283,218,344 | 282,690,975 | 273,039,997 | 151,249,219 | 151,090,227 | 150,537,752 | 150,383,261 | 149,699,528 | 149,333,258 | 121,024,938 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $716.0K | $723.0K | $743.0K | $755.0K | $787.0K | $822.0K | $865.0K | $842.0K | $1M | $998.0K | $942.0K | $941.0K | $955.0K | $894.0K | $933.0K | $771.0K | |
| Stock-based Comp | $10M | $8M | $6M | $6M | $6M | $7M | $6M | $7M | $7M | $7M | $6M | $6M | $7M | $7M | $5M | $5M | |
| Other Non-cash | · | $147M | · | · | · | $-8M | · | · | · | $-6M | · | · | · | $-898.0K | · | · | |
| Operating Cash Flow | $-27M | $-27M | $-22M | $-22M | $-21M | $-32M | $-25M | $-22M | $-29M | $-33M | $-25M | $-24M | $-26M | $-26M | $-26M | $-24M | |
| CapEx | $8.0K | $36.0K | $9.0K | $6.0K | $30.0K | $83.0K | $0 | $5.0K | $13.0K | $42.0K | $82.0K | $240.0K | $247.0K | $1M | $864.0K | $2M | |
| Investing Cash Flow | $19M | $-244M | $25M | $26M | $16M | $34M | $23M | $-103M | $-87M | $10M | $5M | $-2M | $-109M | $15M | $-5M | $-55M | |
| Stock Issued | $0 | $259M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $259M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $3M | $245M | $575.0K | $41.0K | $447.0K | $33.0K | $801.0K | $21M | $212M | $7M | $456.0K | $7.0K | $649.0K | $183.0K | $96M | $427.0K | |
| Net Change in Cash | $-5M | $-27M | $4M | $4M | $-4M | $3M | $-1M | $-104M | $96M | $-16M | $-20M | $-26M | $-134M | $-11M | $65M | $-79M | |
| Free Cash Flow | · | $-27M | · | · | · | $-32M | · | · | · | $-33M | · | · | · | $-28M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -10.0% | -39.3% | · | -6.5% | -7.0% | -7.4% | · | -6.6% | -13.1% | -8.4% | · | -7.0% | -7.2% | -7.0% | · | -7.3% | |
| ROE | -12.0% | -46.3% | · | -7.7% | -8.2% | -9.0% | · | -7.9% | -15.5% | -10.4% | · | -8.6% | -8.4% | -8.2% | · | -8.4% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.3 | 9.5 | · | 10.4 | 11.0 | 12.4 | · | 11.0 | 16.8 | 10.1 | · | 11.4 | 13.9 | 15.6 | · | 13.2 | |
| Quick Ratio | 8.0 | 9.1 | · | 10.0 | 10.7 | 12.0 | · | 10.6 | 16.4 | 9.8 | · | 11.1 | 13.6 | 15.3 | · | 12.9 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.16 | $1.27 | · | $1.23 | $1.31 | $1.41 | · | $1.59 | $1.65 | $1.91 | · | $2.25 | $2.41 | $2.58 | · | $3.02 | |
| Cash Flow / Share | · | $-0.09 | · | · | · | $-0.11 | · | · | · | $-0.22 | · | · | · | $-0.18 | · | · | |
| Cash / Share | $0.14 | $0.15 | · | $0.25 | $0.23 | $0.25 | · | $0.24 | $0.63 | $0.51 | · | $0.75 | $0.92 | $1.82 | · | $1.81 | |
| Dividend / Share | $0.00 | $0.00 | $0.00 | $0.00 | · | · | · | · | · | · | · | · | · | · | · | · | |
| EPS (TTM) | $-0.95 | $-0.93 | · | $-0.40 | $-0.40 | $-0.57 | · | $-0.83 | $-0.92 | $-0.84 | · | $-1.72 | $-1.81 | $-1.90 | · | $-0.85 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-287M | $-277M | · | $-128M | $-128M | $-158M | · | $-159M | $-158M | $-127M | · | $-231M | $-236M | $-240M | · | $-138M | |
| Market Cap | $5.73B | $5.03B | · | $618M | $360M | $388M | · | $772M | $644M | $312M | · | $297M | $415M | $451M | · | $944M | |
| P/E | -19.3 | -17.4 | · | -5.5 | -3.2 | -2.4 | · | -3.3 | -2.6 | -2.5 | · | -1.1 | -1.5 | -1.6 | · | -9.2 | |
| P/B | 15.8 | 12.8 | · | 1.8 | 1.0 | 1.0 | · | 1.7 | 1.4 | 1.1 | · | 0.9 | 1.1 | 1.2 | · | 2.6 | |
| P / Tangible Book | 15.8 | 12.8 | · | 1.8 | 1.0 | 1.0 | · | 1.7 | 1.4 | 1.1 | · | 0.9 | 1.1 | 1.2 | · | 2.6 | |
| P / Cash Flow | · | -183.6 | · | · | · | -12.3 | · | · | · | -9.4 | · | · | · | -17.1 | · | · | |
| Earnings Yield | -5.2% | -5.8% | · | -18.4% | -31.5% | -41.6% | · | -30.4% | -39.0% | -40.8% | · | -87.3% | -65.6% | -63.1% | · | -10.9% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Net Income | $-125M | $-162M | $-125M | $-243M | $-123M |
| Diluted EPS | $-0.44 | $-0.69 | $-0.83 | $-1.99 | $-1.85 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 10.0 | 9.8 | 12.3 | 9.1 | 15.9 |
| Quick Ratio | 9.7 | 9.5 | 11.9 | 8.9 | 15.7 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-96M | $-109M | $-103M | $-118M | $-91M |
Institutional owners (13F) 274 filers · $4.9B total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
274
Value held
$4.9B
New positions
66
Exited positions
26
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 66 (-31 vs prior Q) | 26 (+5 vs prior Q) | 108 (+28 vs prior Q) | 75 (+36 vs prior Q) | +14.2M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | $457,545,444 | 24,975,188 | 9.38% | Shares |
| BlackRock, Inc. | $387,543,955 | 21,154,146 | 7.94% | Shares |
| RTW INVESTMENTS, LP | $328,784,533 | 17,946,754 | 6.74% | Shares |
| Venrock Adviser, LLC | $327,777,996 | 17,891,812 | 6.72% | Shares |
| STATE STREET CORP | $223,221,048 | 12,184,555 | 4.58% | Shares |
| Logos Global Management LP | $222,588,000 | 12,150,000 | 4.56% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $208,888,286 | 11,402,199 | 4.28% | Shares |
| Siren, L.L.C. | $208,807,348 | 11,397,781 | 4.28% | Shares |
| Paradigm Biocapital Advisors LP | $174,956,000 | 9,550,000 | 3.59% | Shares |
| ARCH Venture Management, LLC | $129,917,324 | 7,091,557 | 2.66% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $119,128,739 | 6,501,426 | 2.44% | Shares |
| Cormorant Asset Management, LP | $109,920,000 | 6,000,000 | 2.25% | Shares |
| Affinity Asset Advisors, LLC | $96,180,000 | 5,250,000 | 1.97% | Shares |
| Vivo Capital, LLC | $75,614,188 | 4,127,412 | 1.55% | Shares |
| GOLDMAN SACHS GROUP INC | $70,021,110 | 3,822,113 | 1.44% | Shares |
| Caption Management, LLC | $68,535,120 | 3,741,000 | 1.40% | Call option |
| ALLIANCEBERNSTEIN L.P. | $66,639,175 | 4,118,614 | 1.37% | Shares |
| JANUS HENDERSON GROUP PLC | $59,987,765 | 3,710,966 | 1.23% | Shares |
| BANK OF AMERICA CORP /DE/ | $55,852,862 | 3,048,737 | 1.14% | Shares |
| FMR LLC | $52,824,202 | 2,883,417 | 1.08% | Shares |
| a16z Capital Management, L.L.C. | $52,441,000 | 2,862,500 | 1.07% | Shares |
| Woodline Partners LP | $51,879,803 | 2,831,867 | 1.06% | Shares |
| JENNISON ASSOCIATES LLC | $51,083,708 | 2,788,412 | 1.05% | Shares |
| Soleus Capital Management, L.P. | $49,464,000 | 2,700,000 | 1.01% | Shares |
| VANGUARD GROUP INC | $47,661,220 | 12,812,156 | 0.98% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $43,782,308 | 2,389,864 | 0.90% | Shares |
| SAMLYN CAPITAL, LLC | $41,347,983 | 2,256,986 | 0.85% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $37,410,063 | 2,042,034 | 0.77% | Shares |
| NORTHERN TRUST CORP | $35,872,759 | 1,958,120 | 0.74% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $35,628,553 | 1,944,790 | 0.73% | Shares |
| VICTORY CAPITAL MANAGEMENT INC | $35,475,984 | 1,936,462 | 0.73% | Shares |
| Nuveen, LLC | $33,740,585 | 1,841,735 | 0.69% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $32,315,360 | 1,763,980 | 0.66% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $31,107,195 | 1,697,991 | 0.64% | Shares |
| UBS Group AG | $29,250,848 | 1,596,662 | 0.60% | Shares |
| STEMPOINT CAPITAL LP | $28,687,526 | 1,565,913 | 0.59% | Shares |
| Rock Springs Capital Management LP | $25,687,388 | 1,402,150 | 0.53% | Shares |
| Evergreen Quality Fund GP, Ltd. | $25,195,496 | 1,375,300 | 0.52% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $25,078,578 | 1,368,918 | 0.51% | Shares |
| FRED ALGER MANAGEMENT, LLC | $23,970,896 | 1,308,455 | 0.49% | Shares |
| SILVERARC CAPITAL MANAGEMENT, LLC | $23,138,636 | 1,263,026 | 0.47% | Shares |
| Point72 Asset Management, L.P. | $22,848,759 | 1,247,203 | 0.47% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $22,780,920 | 1,243,500 | 0.47% | Call option |
| First Turn Management, LLC | $22,381,929 | 1,221,721 | 0.46% | Shares |
| FEDERATED HERMES, INC. | $19,827,040 | 1,082,262 | 0.41% | Shares |
| Caption Management, LLC | $19,075,242 | 1,041,225 | 0.39% | Shares |
| Integral Health Asset Management, LLC | $18,320,000 | 1,000,000 | 0.38% | Shares |
| D. E. Shaw & Co., Inc. | $17,396,489 | 949,590 | 0.36% | Shares |
| MILLENNIUM MANAGEMENT LLC | $16,667,792 | 909,814 | 0.34% | Shares |
| Invesco Ltd. | $15,838,135 | 864,527 | 0.32% | Shares |
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund II, LP, Cormorant Private Healthcare GP II, LLC, Cormorant Asset Management, LP, Bihua Chen ×4 filings | Jan. 30, 2024 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 14 insiders · 5 officers · 9 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Jonathan E Lim | Chairman & CEO | Jan. 29, 2026 A | 12,899,360 | 0 | 0 | $0 |
| David M. Chacko | CFO and CBO | Jan. 29, 2026 A | 279,980 | 0 | 0 | $0 |
| Ebun Garner | Chief Legal Officer | April 1, 2026 M | 25,076 | 0 | 2 | $-1,982,800 |
| Shannon Morris | Chief Medical Officer | March 4, 2025 M | 0 | 0 | 1 | $-300,800 |
| Lin Wei | Chief Medical Officer | Feb. 1, 2023 A | 315,812 | 0 | 0 | $0 |
| James Arthur Bristol | Director | June 26, 2026 A | 20,000 | 0 | 0 | $0 |
| Valerie Denise Harding Start | Director | June 26, 2026 A | 20,000 | 0 | 0 | $0 |
| Pratik S Multani | Director | June 26, 2026 A | 6,200 | 0 | 0 | $0 |
| Julie Hambleton | Director | June 26, 2026 A | 6,000 | 0 | 0 | $0 |
| Alexander W. Casdin | Director | June 26, 2026 A | 573,974 | 0 | 0 | $0 |
| Jean I Liu | Director | June 26, 2026 A | · | 0 | 0 | $0 |
| Michael David Varney | Director | Jan. 29, 2026 A | · | 0 | 0 | $0 |
| Chen Bihua | Director | June 22, 2022 A | 10,505,553 | 0 | 0 | $0 |
| Charles S. Fuchs | · | Aug. 10, 2026 A | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 35 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| PTH · Invesco Exchange-Traded Fund Trust | 2.26% | 567,358 SH | Oct. 1, 2026 | Daily |
| DWAS · Invesco Exchange-Traded Fund Trust … | 1.42% | 395,404 SH | Oct. 1, 2026 | Daily |
| LABU · Direxion Shares ETF Trust | 0.93% | 252,386 NS | July 31, 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0.87% | 22,122 NS | July 31, 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 0.39% | 1,956 NS | July 31, 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.34% | 24,747 SH | Oct. 1, 2026 | Daily |
| IBB · iShares Trust | 0.29% | 1,881,079 SH | Sept. 11, 2026 | Daily |
| ESSC · Strategy Shares | 0.28% | 5,493 NS | July 31, 2026 | N-PORT |
| PWS · Pacer Funds Trust | 0.26% | 3,448 NS | July 31, 2026 | N-PORT |
| IWO · iShares Trust | 0.23% | 2,068,727 SH | Sept. 11, 2026 | Daily |
| VFMO · VANGUARD WELLINGTON FUND | 0.22% | 244,429 SH | Aug. 19, 2026 | Daily |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.22% | 214,594 SH | Aug. 19, 2026 | Daily |
| BKSE · BNY Mellon ETF Trust | 0.17% | 8,052 NS | July 31, 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0.15% | 59,277 NS | July 31, 2026 | N-PORT |
| RSSL · Global X Funds | 0.13% | 105,514 NS | July 31, 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0.12% | 21,102 SH | Oct. 1, 2026 | Daily |
| IWM · iShares Trust | 0.12% | 5,643,821 SH | Sept. 11, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.11% | 1,151,944 SH | Aug. 19, 2026 | Daily |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.05% | 100,557 SH | Oct. 1, 2026 | Daily |
| VXF · VANGUARD INDEX FUNDS | 0.05% | 2,745,733 SH | Aug. 19, 2026 | Daily |
| FHLC · FIDELITY COVINGTON TRUST | 0.05% | 85,467 NS | July 31, 2026 | N-PORT |
| ESML · iShares Trust | 0.05% | 81,147 SH | Sept. 11, 2026 | Daily |
| VHT · VANGUARD WORLD FUND | 0.04% | 467,663 SH | Aug. 19, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.03% | 263,455 NS | July 31, 2026 | N-PORT |
| WSML · iShares Trust | 0.03% | 10,485 SH | Sept. 11, 2026 | Daily |
| DFAC · Dimensional ETF Trust | 0.02% | 402,637 NS | July 31, 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.01% | 8,386,105 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.01% | 16,688 SH | Aug. 19, 2026 | Daily |
| ITOT · iShares Trust | 0.01% | 334,866 SH | Sept. 11, 2026 | Daily |
| IWV · iShares Trust | 0.00% | 59,143 SH | Sept. 11, 2026 | Daily |
| DFUS · Dimensional ETF Trust | 0.00% | 33,981 NS | July 31, 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 18,981 NS | July 31, 2026 | N-PORT |
| ISCB · iShares Trust | · | 9,786 SH | Sept. 11, 2026 | Daily |
| ISCV · iShares Trust | · | 48,754 SH | Sept. 11, 2026 | Daily |
| SMLF · iShares Trust | · | 239,252 SH | Sept. 11, 2026 | Daily |
ERAS Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 17 analysts
BUY
Median target
$22.00
+49.3%
5 29.4%
Strong Buy
9 52.9%
Buy
3 17.6%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
9 analysts · 2026-09-27Mean target $24.11 +63.6%
← Below all targets
Current price $14.74
Low$20.00
Mean$24.11
High$33.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| ERAS | $1.06B | -8.5 | · | · | -35.7% | · |
| COGT | $5.72B | -16.4 | · | · | -83.1% | · |
| MIRM | $4.10B | -168.1 | 54.7% | -4.5% | -8.2% | · |
| TVTX | $3.47B | -131.8 | 110.5% | -5.2% | -34.6% | · |
| PTCT | $6.19B | 9.8 | 114.5% | 39.4% | -331.5% | · |
| DNTH | $1.78B | -9.8 | -67.3% | -7973.3% | -40.8% | · |
| RLAY | $1.47B | -5.3 | 53.4% | -1800.6% | -44.9% | · |
| TNGX | $1.20B | -10.2 | 48.3% | -162.8% | -42.2% | · |
Latest News Recent headlines mentioning this company
Here is Why Erasca (ERAS) is One of the Best Growth Stocks Under $20
Yahoo Finance · 3 months, 4 weeks ago
Why This Fund Made a $189 Million Bet on Erasca as Shares Skyrocket 800%
Nasdaq · 4 months ago
Acuta Capital Bet on Erasca (ERAS) and Targeted Cancer Treatments With a 354,575 Share Buy
Nasdaq · 4 months, 2 weeks ago
JPMorgan Recommends Buying Erasca (ERAS) Stock at Current Levels
Yahoo Finance · 4 months, 3 weeks ago
Erasca (ERAS) Climbs 390% YTD on ‘Best-in-Class’ Potential of Cancer Treatment
Yahoo Finance · 5 months, 2 weeks ago
What’s Driving Erasca (ERAS)’s Nearly 355% YTD Return
Yahoo Finance · 5 months, 3 weeks ago
Erasca (ERAS) Adds 13%; Soars 310% YTD
Yahoo Finance · 6 months, 1 week ago
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 11, 2026